NASDAQ:HTGM

HTG Molecular Diagnostics SEC Filings & 10K Form

$4.93
-0.23 (-4.46 %)
(As of 06/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.85
$5.30
50-Day Range
$3.52
$5.16
52-Week Range
$3.50
$13.80
Volume92,275 shs
Average Volume135,974 shs
Market Capitalization$30.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.36

HTG Molecular Diagnostics (NASDAQ:HTGM) SEC Filings

DateFilerForm TypeView
06/14/2021
7:32 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
7:30 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
7:24 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
7:21 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
5:22 AM
HIRSCHMAN ORIN (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G
04/05/2021
3:09 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
4:49 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:47 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:45 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2021
4:24 PM
HTG Molecular Diagnostics (Filer)
Form 424B5
02/16/2021
10:37 AM
HTG Molecular Diagnostics (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
02/16/2021
5:23 AM
HTG Molecular Diagnostics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G/A
02/12/2021
4:05 PM
HTG Molecular Diagnostics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/11/2021
11:58 AM
HTG Molecular Diagnostics (Subject)
Samjo Capital LLC (Filed by)
Form SC 13G/A
01/19/2021
3:05 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2021
3:06 PM
HTG Molecular Diagnostics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/06/2021
7:00 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
7:15 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
5:00 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:57 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:55 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:53 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:14 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:13 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:12 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:10 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:08 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:15 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
3:16 PM
HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/02/2020
4:47 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
4:39 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
4:37 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
4:35 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:04 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:01 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:00 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
4:59 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
4:54 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:38 PM
HTG Molecular Diagnostics (Issuer)
LAFRANCE JAMES T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:14 PM
HTG Molecular Diagnostics (Issuer)
McCracken Lee R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:06 PM
HANHAM ANN (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:53 PM
GRIFFIN MICHELLE RENEE (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:48 PM
George Harry A. (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
4:18 PM
HTG Molecular Diagnostics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/20/2020
3:00 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
3:10 PM
HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2020
3:06 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
11:52 AM
HTG Molecular Diagnostics (Filer)
Form CT ORDER
07/07/2020
3:15 PM
HTG Molecular Diagnostics (Filer)
Form DEFA14A
07/07/2020
3:05 PM
HTG Molecular Diagnostics (Filer)
Form DEF 14A
06/26/2020
4:22 PM
HTG Molecular Diagnostics (Filer)
Form PRE 14A
06/25/2020
3:45 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
5:21 PM
HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:19 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:17 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:15 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:13 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
8:11 PM
Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G/A
05/13/2020
3:10 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2020
5:05 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
4:28 PM
HTG Molecular Diagnostics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2020
11:35 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
8:46 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
8:43 PM
HTG Molecular Diagnostics (Filer)
Form 424B5
02/26/2020
7:22 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:23 AM
HTG Molecular Diagnostics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G
02/04/2020
9:35 AM
Cowen Prime Services LLC (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G
01/31/2020
2:29 PM
HTG Molecular Diagnostics (Subject)
Samjo Capital LLC (Filed by)
Form SC 13G
01/27/2020
4:26 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
3:40 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:38 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:37 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:05 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2020
3:53 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:52 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:50 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:42 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:36 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:32 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
11:15 PM
HTG Molecular Diagnostics (Filer)
Form EFFECT
11/18/2019
3:15 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
3:07 PM
HTG Molecular Diagnostics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/10/2019
10:35 AM
FMR LLC (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G/A
10/07/2019
5:03 AM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
3:29 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:27 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
10:05 AM
HTG Molecular Diagnostics (Subject)
Serrado Capital LLC (Filed by)
Form SC 13G
09/30/2019
7:38 AM
Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G
09/27/2019
5:52 PM
HTG Molecular Diagnostics (Issuer)
LYTTON LAURENCE W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/23/2019
4:19 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
4:16 PM
HTG Molecular Diagnostics (Filer)
Form 424B5
09/19/2019
3:05 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
3:02 PM
HTG Molecular Diagnostics (Filer)
Form 424B5
09/16/2019
3:45 PM
HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
3:42 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:20 PM
HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:28 PM
HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
4:24 PM
HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
4:20 PM
Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:34 PM
GRIFFIN MICHELLE RENEE (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.